These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 3061638

  • 1. Treatment of tardive dyskinesia.
    Roos RA, Buruma OJ, de Wolff FA.
    Clin Neuropharmacol; 1988 Aug; 11(4):386. PubMed ID: 3061638
    [No Abstract] [Full Text] [Related]

  • 2. Atypical neuroleptics: clozapine and the benzamides in the prevention and treatment of tardive dyskinesia.
    Pi EH, Simpson GM.
    Mod Probl Pharmacopsychiatry; 1983 Aug; 21():80-6. PubMed ID: 6140635
    [No Abstract] [Full Text] [Related]

  • 3. Tiapride: effects on tardive dyskinesia and on prolactin plasma concentrations.
    Greil W, Auberger S, Haag H, Rüther E.
    Neuropsychobiology; 1985 Aug; 14(1):17-22. PubMed ID: 3906426
    [Abstract] [Full Text] [Related]

  • 4. Tiapride in the treatment of tardive dyskinesia.
    Buruma OJ, Roos RA, Bruyn GW, Kemp B, van der Velde EA.
    Acta Neurol Scand; 1982 Jan; 65(1):38-44. PubMed ID: 6121443
    [Abstract] [Full Text] [Related]

  • 5. Treatment of permanent tardive dyskinesia with tiapride, a selective D2-receptor blocking agent.
    Leblhuber F.
    Clin Neuropharmacol; 1987 Oct; 10(5):458-61. PubMed ID: 2902921
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of tardive dyskinesia.
    Deleu D.
    Am J Psychiatry; 1988 Sep; 145(9):1182-3. PubMed ID: 2901238
    [No Abstract] [Full Text] [Related]

  • 7. Effects of tiapride in tardive dyskinesia.
    Pollak P, Gaio JM, Hommel M, Pellat J, Perret J.
    Psychopharmacology (Berl); 1985 Sep; 85(2):236-9. PubMed ID: 3925489
    [Abstract] [Full Text] [Related]

  • 8. Assessment of the therapeutic range of tiapride in patients with tardive dyskinesia.
    Roos RA, Van der Velde EA, Buruma OJ, de Wolff FA.
    J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1055-8. PubMed ID: 3760895
    [Abstract] [Full Text] [Related]

  • 9. Tiapride in levodopa-induced involuntary movements.
    Mejer Nielsen B.
    Acta Neurol Scand; 1983 Jun; 67(6):372-5. PubMed ID: 6351529
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of tiapride in patients with tardive dyskinesia and Huntington's disease.
    Roos RA, de Haas EJ, Buruma OJ, de Wolff FA.
    Eur J Clin Pharmacol; 1986 Jun; 31(2):191-4. PubMed ID: 2948825
    [Abstract] [Full Text] [Related]

  • 11. [Therapy of extrapyramidal motor disturbances by tiaprid (author's transl)].
    Claus D, Aschoff JC.
    Arch Psychiatr Nervenkr (1970); 1979 Jun; 227(2):151-8. PubMed ID: 44462
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tiapride in the treatment of Huntington's chorea.
    Roos RA, Buruma OJ, Bruyn GW, Kemp B, van der Velde EA.
    Acta Neurol Scand; 1982 Jan; 65(1):45-50. PubMed ID: 6461156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Baclofen in the treatment of tardive dyskinesia.
    Nair NP, Yassa R, Ruiz-Navarro J, Schwartz G.
    Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cataplexy relieved by tiapride.
    Paulus W, Hömberg V, Noth J.
    Arch Neurol; 1983 Dec; 40(13):828. PubMed ID: 6639414
    [No Abstract] [Full Text] [Related]

  • 20. Tardive dystonia. The benefits of time.
    Cooper SJ, Doherty MM, King DJ.
    Br J Psychiatry; 1989 Jul; 155():113-5. PubMed ID: 2691000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.